Alyeska Investment Group
OM icon

Alyeska Investment Group’s Outset Medical OM Stock Holding History

Alyeska Investment Group’s Portfolio OM Stock Details OM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,614,582
Closed -$5.99M – 712
2025
Q4 		$5.99M Hold
1,614,582
– – 0.02% 440
2025
Q3 		$22.8M Buy
1,614,582
+150,000
+10% +$2.34M 0.07% 274
2025
Q2 		$28.1M Sell
1,464,582
-238,501
-14% -$3.72M 0.1% 234
2025
Q1 		$18.8M Buy
+1,703,083
New +$20.3M 0.08% 252
2021
Q1 		– Sell
-2,694
Closed -$2.3M – 805
2020
Q4 		$2.3M Sell
2,694
-338
-11% -$260K 0.03% 359
2020
Q3 		$2.27M Buy
+3,032
New +$2.49M 0.03% 338

Other funds holding OM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $53.7B AUM 29.47% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Alyeska Investment Group's OM Position: Q1 2026 in Review

Alyeska Investment Group sold out of Outset Medical (OM) in Q1 2026, closing a stake of 1,614,582 shares — an estimated $5.99M sold.

Alyeska Investment Group first reported a position in OM in Q3 2020 and held it in 6 quarters. The position peaked at $28.1M in Q2 2025. 99 funds tracked by Wall St. Rank hold OM as of Q1 2026.

  • Alyeska Investment Group reported no remaining Outset Medical position as of Q1 2026 after selling out during the quarter.
  • Alyeska Investment Group sold 1,614,582 Outset Medical shares in Q1 2026, an estimated $5.99M.
  • Alyeska Investment Group first reported a position in Outset Medical in Q3 2020 and held it in 6 quarters.
  • Alyeska Investment Group's Outset Medical position peaked at $28.1M in Q2 2025.
  • 99 funds tracked by Wall St. Rank held Outset Medical as of Q1 2026.

Based on Alyeska Investment Group's 13F filing for Q1 2026, filed 15 May 2026.